Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 13, 2012 - Issue 5
Submit an article Journal homepage
540
Views
12
CrossRef citations to date
0
Altmetric
Drug Evaluations

Everolimus: preventing organ rejection in adult kidney transplant recipients

Jacques DantalITUN, Nephrology, Clinical Immunology & Transplantation, 30 bd Jean Monnet, Immeuble Jean Monnet, Hôtel Dieu, Nantes 44093, [email protected]
Pages 767-778 | Published online: 12 Mar 2012

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Lingaku Lee, Tetsuhide Ito & Robert T. Jensen. (2018) Everolimus in the treatment of neuroendocrine tumors: efficacy, side-effects, resistance, and factors affecting its place in the treatment sequence. Expert Opinion on Pharmacotherapy 19:8, pages 909-928.
Read now
Fabian Halleck, Michael Duerr, Johannes Waiser, Lu Huber, Mareen Matz, Susanne Brakemeier, Lutz Liefeldt, Hans-Hellmut Neumayer & Klemens Budde. (2012) An evaluation of sirolimus in renal transplantation. Expert Opinion on Drug Metabolism & Toxicology 8:10, pages 1337-1356.
Read now

Articles from other publishers (10)

Yujiro Geka, Yukihiro Hamada, Shohei Fuchinoue & Toshimi Kimura. (2022) Evaluation of factors influencing the ratio of the trough blood concentration to dose level of everolimus in Japanese kidney transplant recipients. Transplant Immunology 73, pages 101609.
Crossref
Klemens Budde, Martin Zeier, Oliver Witzke, Wolfgang Arns, Frank Lehner, Markus Guba, Johannes Jacobi, Volker Kliem, Petra Reinke, Ingeborg A. Hauser, Bruno Vogt, Rolf Stahl, Thomas Rath, Michael Duerr, Eva-Maria Paulus, Christoph May, Martina Porstner & Claudia Sommerer. (2017) Everolimus with cyclosporine withdrawal or low-exposure cyclosporine in kidney transplantation from Month 3: a multicentre, randomized trial. Nephrology Dialysis Transplantation 32:6, pages 1060-1070.
Crossref
J. Teranishi, Y. Hattori, T. Mochizuki, T. Kawahara, K. Makiyama & H. Uemura. (2016) Effective Treatment With Everolimus for Recurrent Granulomatous Interstitial Nephritis in a Renal Transplant Recipient: A Case Report. Transplantation Proceedings 48:3, pages 946-948.
Crossref
Esther K Schmitt, D Hoepfner & P Krastel. (2016) Natural products as probes in pharmaceutical research. Journal of Industrial Microbiology and Biotechnology 43:2-3, pages 249-260.
Crossref
Oliver Witzke, Claudia Sommerer & Wolfgang Arns. (2016) Everolimus immunosuppression in kidney transplantation: What is the optimal strategy?. Transplantation Reviews 30:1, pages 3-12.
Crossref
David N. Franz, Karen Agricola, Maxwell Mays, Cindy Tudor, Marguerite M. Care, Katherine Holland‐Bouley, Noah Berkowitz, Sara Miao, Séverine Peyrard & Darcy A. Krueger. (2015) Everolimus for subependymal giant cell astrocytoma: 5‐year final analysis. Annals of Neurology 78:6, pages 929-938.
Crossref
Delphine Buthiau, Anne-Sophie Bargnoux, Stéphanie Badiou, Thibault Sutra, Anne-Marie Dupuy, Georges-Philippe Pageaux, Georges Mourad & Jean-Paul Cristol. (2015) Evaluation of QMS Everolimus Assay Using Indiko Analyzer. Therapeutic Drug Monitoring 37:2, pages 275-278.
Crossref
Michael J.G. Somers & Elahna Paul. (2015) Safety considerations of mammalian target of rapamycin inhibitors in tuberous sclerosis complex and renal transplantation. The Journal of Clinical Pharmacology 55:4, pages 368-376.
Crossref
F. Cicora, P. Massari, F. Acosta, H. Petrone, R. Cambariere, I. González, N. Imperiali, F. López, A. Otero & J. Roberti. (2014) Use of Everolimus in Renal Transplant Recipients: Data From a National Registry. Transplantation Proceedings 46:9, pages 2991-2995.
Crossref
. (2012) Current World Literature. Current Opinion in Organ Transplantation 17:6, pages 688-699.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.